- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00396539
Hydrogen Sulfide Production by Oral Microflora
February 1, 2009 updated by: Hadassah Medical Organization
Detection of Hydrogen Sulfide Production by Oral Microflora Samples
Oral malodor is a common condition.
In most cases this condition results from the proteolytic activity of anaerobic oral bacteria.
These bacteria produce volatile sulfide compounds which are fowl smelling and are felt during exhalation and speech.
the aim of the present study is to examine a simple method of detecting these bacteria in samples taken from the oral cavity of oral malodor patients.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jerusalem, Israel
- Hadassah Medical Organization
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- oral malodor patients
Exclusion Criteria:
- smokers, users of antibiotic one month prior to study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nir Sterer, Dr., Hadassah Medical Organization
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Actual)
August 1, 2008
Study Completion (Actual)
September 1, 2008
Study Registration Dates
First Submitted
November 6, 2006
First Submitted That Met QC Criteria
November 6, 2006
First Posted (Estimate)
November 7, 2006
Study Record Updates
Last Update Posted (Estimate)
February 3, 2009
Last Update Submitted That Met QC Criteria
February 1, 2009
Last Verified
November 1, 2006
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 29.12.06-19-HMO-CTIL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Malodor (Halitosis)
-
Riyadh Colleges of Dentistry and PharmacyCompleted
-
Hadassah Medical OrganizationCompletedHalitosis | Bad Breath | Oral MalodorIsrael
-
Novozymes A/SCompletedOral MalodorUnited States
-
Rowpar Pharmaceuticals, Inc.Loma Linda UniversityCompletedOral Malodor
-
Rowpar Pharmaceuticals, Inc.University Health Resources GroupCompletedOral Malodor
-
Procter and GambleCompletedOral MalodorUnited States
-
UConn HealthCompletedOral Hygiene | HalitosisUnited States
-
Dose Biosystems Inc.Completed
-
Al-Baha UniversityCompletedOral Odor (Halitosis) | The Study Want to Know if Site Specific Mouth Rinsing With Oral Mouth Disinfectants Can be Better Than Paonoral Mouth Rinsing